- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04356612
Barriers to Efficient PACU Discharge at a Major Academic Orthopaedic Ambulatory Surgery Center
January 4, 2024 updated by: Hospital for Special Surgery, New York
This is a retrospective chart review to determine the etiologies contributing to prolonged PACU discharge at a major Orthopedic Ambulatory Center
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Increasing number of surgeries are now performed at ambulatory surgical centers including orthopaedic procedures.
While healthier patients usually undergo non-major orthopaedic procedures using regional anesthesia to facilitate faster discharges, prolonged PACU discharges are frequently encountered necessitating characterization and identification of modifiable variables.
This is a retrospective chart review to determine the etiologies contributing to prolonged PACU discharge at a major Orthopedic Ambulatory Center.
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- Hospital for Special Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
patients undergoing ambulatory foot and ankle surgery
Description
Inclusion Criteria:
- Adult patients (18 years and older) undergoing ambulatory foot and ankle surgery
Exclusion Criteria:
- n/a
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Achilles Tendon Rupture
This is a retrospective chart review to determine the etiologies contributing to prolonged PACU discharge at a major Orthopedic Ambulatory Surgical Center.
|
This is a retrospective chart review to determine the etiologies contributing to prolonged PACU discharge at a major Orthopedic Ambulatory Surgical Center.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time required for discharge
Time Frame: Day of surgery (Day 0) through discharge, average of 6 hours
|
This is the length of time that patients stay in the recovery room
|
Day of surgery (Day 0) through discharge, average of 6 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Supplemental Analgesics
Time Frame: Day of surgery (Day 0) through discharge, average of 6 hours
|
This is the amount of pain medication patients require in the recovery room
|
Day of surgery (Day 0) through discharge, average of 6 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sang Kim, MD, Hospital for Special Surgey
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 20, 2019
Primary Completion (Estimated)
November 6, 2025
Study Completion (Estimated)
November 6, 2025
Study Registration Dates
First Submitted
April 20, 2020
First Submitted That Met QC Criteria
April 20, 2020
First Posted (Actual)
April 22, 2020
Study Record Updates
Last Update Posted (Actual)
January 5, 2024
Last Update Submitted That Met QC Criteria
January 4, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-1643
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Achilles Tendon Rupture
-
Aristotle University Of ThessalonikiGeneral Hospital of Naoussa; Private Orthopedics Practice P. SymeonidisEnrolling by invitationAchilles Tendon Rupture | Achilles Tendon Injury | Achilles Tendon SurgeryGreece
-
Henry Ford Health SystemRecruitingAchilles Tendon Rupture | Achilles Tendon SurgeryUnited States
-
Aarhus University HospitalEnrolling by invitationAchilles Tendon Rupture | Achilles Tendon InjuryDenmark
-
Chinese University of Hong KongNot yet recruitingAchilles Tendinopathy | Achilles Tendon RuptureHong Kong
-
Penn State UniversityRecruiting
-
Bispebjerg HospitalCompletedAchilles Tendon RuptureDenmark
-
Region SkaneLund UniversityCompleted
-
Hvidovre University HospitalCompletedAchilles Tendon RuptureDenmark
-
Peking University Third HospitalCompletedAchilles Tendon RuptureChina
-
University of OxfordNational Institute for Health Research, United KingdomCompletedAchilles Tendon RuptureUnited Kingdom
Clinical Trials on Chart Review
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMalignant Central Nervous System Neoplasm | Malignant Skull Base NeoplasmUnited States
-
Louisiana State University Health Sciences Center...Recruiting
-
M.D. Anderson Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterRecruitingCutaneous MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHead and Neck CarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Recurrent Uterine Corpus Carcinoma | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Recurrent Cervical Carcinoma | Stage III Uterine Sarcoma | Stage IV Uterine Sarcoma | Stage I Uterine... and other conditionsUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLCCompletedIncidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin AmericaHIV Infection | Malignant Neoplasm | Recurrent Malignant Neoplasm | Human Immunodeficiency Virus 1 PositiveMexico, Argentina, Brazil
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Neoplasm | Malignant Respiratory Tract Neoplasm | Malignant Thoracic NeoplasmUnited States, Cyprus